我斗神
2021-02-17
苏踏踏 听！TV58 是
DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Clover Health Investments, Corp. – CLOV, CLOVW, IPOC
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":385259518,"tweetId":"385259518","gmtCreate":1613557222334,"gmtModify":1613557222334,"author":{"id":3489705817352597,"idStr":"3489705817352597","authorId":3489705817352597,"authorIdStr":"3489705817352597","name":"我斗神","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>苏踏踏 听！TV58 是 </p></body></html>","htmlText":"<html><head></head><body><p>苏踏踏 听！TV58 是 </p></body></html>","text":"苏踏踏 听！TV58 是","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/385259518","repostId":2112882414,"repostType":2,"repost":{"id":"2112882414","pubTimestamp":1613494980,"share":"https://www.laohu8.com/m/news/2112882414?lang=&edition=full","pubTime":"2021-02-17 01:03","market":"us","language":"zh","title":"DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Clover Health Investments, Corp. – CLOV, CLOVW, IPOC","url":"https://stock-news.laohu8.com/highlight/detail?id=2112882414","media":"GlobeNewswire","summary":"NEW YORK, Feb. 17, 2021 -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III who: purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive ; and/or purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.If you wish to serve as lead plaintiff, you must move the Court before the April 6, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.","content":"<html><body><p>NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Clover Health Investments, Corp. f/k/a <a href=\"https://laohu8.com/S/IPOC.U\">Social Capital Hedosophia Holdings Corp. III</a> (NASDAQ: CLOV, CLOVW) (NYSE: IPOC) who: (1) purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.<br/></p>\n<p>To join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.</p>\n<p>如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582</p>\n<p>If you wish to serve as lead plaintiff, you must move the Court before the <strong>April 6, 2021 DEADLINE.</strong> A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. </p>\n<p>According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that- Clover’s was under active investigation by the Department of Justice for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals; the DOJ’s investigation presented an existential risk to the Company, since it derives most of its revenues from Medicare; Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology; a significant portion of Clover sales were by way of an undisclosed relationship between Clover and an outside brokerage firm controlled by Clover’s Head of Sales; and as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.</p>\n<p>Lead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time.</p>\n<p>Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.</p>\n<p>Zhang Investor Law P.C.<br/>99 Wall Street, Suite 232<br/>New York, New York 10005<br/>info@zhanginvestorlaw.com<br/>tel: (800) 991-3756<br/></p>\n<br/>\n<img height=\"1\" src=\"https://ml.globenewswire.com/release/track/397ce691-d08f-4fd4-bcbf-4dbc163b6780\" width=\"1\"/></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Clover Health Investments, Corp. – CLOV, CLOVW, IPOC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDEADLINE: Zhang Investor Law Alerts Investors of Deadline in Securities Class Action Lawsuit Against Clover Health Investments, Corp. – CLOV, CLOVW, IPOC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-02-17 01:03 北京时间 <a href=https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html><strong>GlobeNewswire</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Clover Health Investments, Corp. f/k/a Social Capital ...</p>\n\n<a href=\"https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/9ZrC1RTINuwAePNbhMocgQ--~B/aD0xMjU7dz03NzU7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/uu/api/res/1.2/vWhXIXoqEFvlQel1Gatm7Q--~B/aD0xMjU7dz03NzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e259ec0cd2e22aa5c7cb38ac472d47ba","relate_stocks":{"CLOV":"Clover Health Corp","CLOVW":"Clover Health Corp Warrant 2025/04/21 11.5C"},"source_url":"https://finance.yahoo.com/news/deadline-zhang-investor-law-alerts-170300583.html","is_english":false,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2112882414","content_text":"NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Clover Health Investments, Corp. f/k/a Social Capital Hedosophia Holdings Corp. III (NASDAQ: CLOV, CLOVW) (NYSE: IPOC) who: (1) purchased or otherwise acquired publicly traded Clover securities between October 6, 2020 and February 4, 2021, inclusive (the “Class Period”); and/or (2) purchased or otherwise acquired Clover securities pursuant or traceable to the registration statement and prospectus issued in connection with the December 2020 Merger of Clover and Social Capital III.\nTo join the class action, go to http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email info@zhanginvestorlaw.com for information on the class action.\n如果您想加入这个集体诉讼案，请在这里提交您的信息。http://zhanginvestorlaw.com/join-action-form/?slug=clover-health-investments-corp&id=2582\nIf you wish to serve as lead plaintiff, you must move the Court before the April 6, 2021 DEADLINE. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. \nAccording to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that- Clover’s was under active investigation by the Department of Justice for at least 12 issues ranging from kickbacks to marketing practices to undisclosed third-party deals; the DOJ’s investigation presented an existential risk to the Company, since it derives most of its revenues from Medicare; Clover’s sales were driven by a major undisclosed related party deal and misleading marketing targeting the elderly, not its purported “best-in-class” technology; a significant portion of Clover sales were by way of an undisclosed relationship between Clover and an outside brokerage firm controlled by Clover’s Head of Sales; and as a result, Defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.\nLead plaintiff status is not required to seek compensation. You may retain counsel of your choice. You may remain an absent class member and take no action at this time.\nZhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.\nZhang Investor Law P.C.99 Wall Street, Suite 232New York, New York 10005info@zhanginvestorlaw.comtel: (800) 991-3756","news_type":1},"isVote":1,"tweetType":1,"viewCount":1592,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":15,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/385259518"}
精彩评论